Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$47.98 - $54.4 $205,210 - $232,668
-4,277 Reduced 11.86%
31,778 $1.72 Million
Q4 2023

Jan 23, 2024

SELL
$48.48 - $57.85 $85,518 - $102,047
-1,764 Reduced 4.66%
36,055 $1.85 Million
Q3 2023

Oct 24, 2023

SELL
$57.89 - $64.73 $77,804 - $86,997
-1,344 Reduced 3.43%
37,819 $2.2 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $97,922 - $108,727
-1,537 Reduced 3.78%
39,163 $2.5 Million
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $49,348 - $55,972
751 Added 1.88%
40,700 $2.82 Million
Q4 2022

Feb 03, 2023

BUY
$68.48 - $81.09 $41,498 - $49,140
606 Added 1.54%
39,949 $2.87 Million
Q3 2022

Nov 04, 2022

SELL
$0.13 - $76.84 $76 - $45,258
-589 Reduced 1.48%
39,343 $2.8 Million
Q2 2022

Jul 29, 2022

SELL
$72.62 - $79.98 $327,225 - $360,389
-4,506 Reduced 10.14%
39,932 $3.08 Million
Q1 2022

Apr 29, 2022

SELL
$61.48 - $73.72 $6,701 - $8,035
-109 Reduced 0.24%
44,438 $3.25 Million
Q4 2021

Feb 03, 2022

SELL
$53.63 - $62.52 $50,144 - $58,456
-935 Reduced 2.06%
44,547 $2.78 Million
Q3 2021

Oct 21, 2021

BUY
$59.17 - $69.31 $40,590 - $47,546
686 Added 1.53%
45,482 $2.69 Million
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $6,005 - $6,539
97 Added 0.22%
44,796 $2.99 Million
Q4 2020

Jan 20, 2021

BUY
$57.74 - $65.43 $26,040 - $29,508
451 Added 1.02%
44,699 $2.77 Million
Q3 2020

Nov 17, 2020

BUY
$57.43 - $63.64 $899,698 - $996,984
15,666 Added 54.81%
44,248 $2.67 Million
Q2 2020

Jul 15, 2020

BUY
$54.82 - $64.09 $1.11 Million - $1.3 Million
20,258 Added 243.37%
28,582 $1.68 Million
Q1 2020

Apr 24, 2020

SELL
$46.4 - $67.43 $9,326 - $13,553
-201 Reduced 2.36%
8,324 $464,000
Q4 2019

Feb 27, 2020

BUY
$49.21 - $64.19 $419,515 - $547,219
8,525 New
8,525 $547,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $108B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Total Clarity Wealth Management, Inc. Portfolio

Follow Total Clarity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.